These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy. Amoedo ND; Obre E; Rossignol R Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330 [TBL] [Abstract][Full Text] [Related]
27. SynLethDB: synthetic lethality database toward discovery of selective and sensitive anticancer drug targets. Guo J; Liu H; Zheng J Nucleic Acids Res; 2016 Jan; 44(D1):D1011-7. PubMed ID: 26516187 [TBL] [Abstract][Full Text] [Related]
28. Predicting drug resistance related to ABC transporters using unsupervised Consensus Self-Organizing Maps. Estrada-Tejedor R; Ecker GF Sci Rep; 2018 May; 8(1):6803. PubMed ID: 29717183 [TBL] [Abstract][Full Text] [Related]
29. Introduction: Cancer Gene Networks. Clarke R Methods Mol Biol; 2017; 1513():1-9. PubMed ID: 27807826 [TBL] [Abstract][Full Text] [Related]
30. MEDICI: Mining Essentiality Data to Identify Critical Interactions for Cancer Drug Target Discovery and Development. Harati S; Cooper LA; Moran JD; Giuste FO; Du Y; Ivanov AA; Johns MA; Khuri FR; Fu H; Moreno CS PLoS One; 2017; 12(1):e0170339. PubMed ID: 28118365 [TBL] [Abstract][Full Text] [Related]
31. [Reversal of drug resistance and prediction of the response to cytostatics. Experimental drug therapy for tumors has clinical potential]. Larsson R; Nygren P; Bergh J Lakartidningen; 1991 Dec; 88(51-52):4441-4. PubMed ID: 1774991 [No Abstract] [Full Text] [Related]
33. Druggable cancer secretome: neoplasm-associated traits. Narayanan R Cancer Genomics Proteomics; 2015; 12(3):119-31. PubMed ID: 25977171 [TBL] [Abstract][Full Text] [Related]
34. Molecular genomic features associated with in vitro response of the NCI-60 cancer cell line panel to natural products. Krushkal J; Negi S; Yee LM; Evans JR; Grkovic T; Palmisano A; Fang J; Sankaran H; McShane LM; Zhao Y; O'Keefe BR Mol Oncol; 2021 Feb; 15(2):381-406. PubMed ID: 33169510 [TBL] [Abstract][Full Text] [Related]
35. New therapeutic targets in cancer: the epigenetic connection. Herranz M; Esteller M Clin Transl Oncol; 2006 Apr; 8(4):242-9. PubMed ID: 16648099 [TBL] [Abstract][Full Text] [Related]
36. Cancer in silico drug discovery: a systems biology tool for identifying candidate drugs to target specific molecular tumor subtypes. San Lucas FA; Fowler J; Chang K; Kopetz S; Vilar E; Scheet P Mol Cancer Ther; 2014 Dec; 13(12):3230-40. PubMed ID: 25349306 [TBL] [Abstract][Full Text] [Related]
37. A tool for discovering drug sensitivity and gene expression associations in cancer cells. Qin Y; Conley AP; Grimm EA; Roszik J PLoS One; 2017; 12(4):e0176763. PubMed ID: 28453553 [TBL] [Abstract][Full Text] [Related]